Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.51 |
| ▸ | HTT | P42858 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29071729 | 0.82 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2HTTLMNAMAPT | |
| SCHEMBL29071736 | 0.79 | ALDH1A1 (0.51) | ALDH1A1SMN1; SMN2HTTLMNAMAPT | |
| SCHEMBL14352700 | 0.78 | DHFR (0.53) | DHFRLMNAMAPTNPC1RAB9A | |
| SCHEMBL29071733 | 0.78 | CNR1 (0.53) | ALDH1A1SMN1; SMN2HTTLMNAMAPT | |
| SCHEMBL27691989 | 0.77 | DHFR (0.51) | DHFRLMNAMAPTKMT2AL3MBTL1 | |
| SCHEMBL11848198 | 0.77 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2HTTLMNAMAPT | |
| SCHEMBL4850756 | 0.77 | POLB (0.43) | DHFRALDH1A1SMN1; SMN2HTTLMNA | |
| SCHEMBL4850760 | 0.77 | POLB (0.43) | DHFRALDH1A1SMN1; SMN2HTTLMNA | |
| SCHEMBL2189025 | 0.74 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2HTTLMNAMAPT | |
| SCHEMBL379309 | 0.74 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2HTTLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7364825-B2 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-29 | — | — | US | disclosed |
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-08-10 | — | — | US | disclosed |
| US-7049312-B1 | Benzothiazinone and benzoxazinone compounds | ABBOTT GMBH & CO. KG (DE) | 2006-05-23 | — | — | US | disclosed |
| EP-1181282-A2 | BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-27 | — | — | EP | disclosed |
| WO-2000075139-A2 | BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177750-A1 | Charge transport materials having a nitrogen-containing-heterocycle hydrazone group | SLC1A2, SLC9B2, SLC6A19 | DHFR 2490/4885ALDH1A1 1928/4885SMN1; SMN2 4064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.